News & Trends - Pharmaceuticals

Landmark special authority for NSW residents affected by bushfires to access essential medicines without a prescription

Health Industry Hub | January 9, 2020 |
[Total: 1    Average: 5/5]

New South Wales (NSW) residents affected by the bushfire crisis will now be able to access a standard PBS or manufacturers pack quantity of their Prescription Only Medicines (Schedule 4) without a prescription following the issuing of a special authority by the NSW Chief Health Officer, a move strongly welcomed by the Pharmaceutical Society of Australia (PSA).

Under the special authority announced last night, NSW pharmacists will be able to supply people affected by the bushfires with standard PBS quantities and standard pack sizes of non-PBS medicines without a prescription when where a pharmacist is satisfied there is an immediate therapeutic need and obtaining a prescription is impractical. In most cases, this represents a months’ supply of that medicine.

Malua Bay Pharmacist, Raj Gupta, has kept his pharmacy doors open in the fires said “Patients I have known for years have come into my pharmacy having lost all their medications in the fires. When you have lost your home, there is no power or telephone and it might be weeks before you can get in to see a doctor, to turn them away with just a few days of life saving medicines to tide them over because of some bureaucratic rule – it just needs to be fixed.”

Prior to this special authority being issued, pharmacists were unable to supply more than three (3) days’ supply of a Prescription Only Medicine without a prescription in an emergency.

In welcoming the announcement, the PSA NSW Branch President Peter Carroll noted “The current bushfires across NSW have resulted in unprecedented demand on pharmacists working in multiple settings, especially in community pharmacy”.

“We have heard many stories and first-hand examples of pharmacists going above and beyond in their support of their communities. But up until now, the inability to supply more than three-days’ supply of medicines to people has been an unacceptable barrier to accessing and providing care to people in these disaster affected zones.”

“This announcement means that people separated from their prescription medicines or prescriptions will be able to access their regular medicines needed for managing chronic health conditions, such as blood pressure, depression, diabetes, asthma or chronic obstructive pulmonary disease (COPD).

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

Similar to other emergency supply provisions, Schedule 4 Appendix D medicines (e.g. benzodiazepines) and Controlled Drugs (Schedule 8) (e.g. opioid pain medicines) cannot be supplied under this provision unless authorised by a medical practitioner by telephone, email or facsimile

“We thank the NSW Ministry of Health for responding to this urgent need and issuing this special authority which is vital to ensure NSW residents affected by bushfires can continue access to medicines vital for their health.” Prof Carroll said “We understand this is the first time such a special authority has been issued in Australia.”

“Unfortunately, emergencies and disasters are regular events in NSW. We are keen to work with the NSW government after this crisis subsides to review how this provision could become engrained in regulation to ensure people are able to access medicines when the next emergency strikes.”

PSA National President, Associate Professor Chris Freeman congratulated the NSW Ministry of Health on this pragmatic and important solution in improving access to medicines in disaster situations. Associate Professor Freeman said “The NSW Government has been the first to listen to calls from the national peak body representing pharmacists. The NSW Government has shown leadership, compassion and a willingness to ensure NSW residents affected by these unprecedented fires can have safe access to medicines in an emergency”.

“The PSA will continue to advocate on behalf of Australians affected by the bushfires and their amazing and courageous pharmacists who care for them, to have nationally consistent emergency supply rules for medicines without having to foot the bill” said Associate Professor Freeman.

The special provision takes effect immediately and expires on 31 March 2020.  PSA will distribute guidance to NSW pharmacists in addition to information published on the NSW Health website.

You may also like Temporary permission granted by TGA to advertise salbutamol puffers and inhalers

Differentiate your business, build thought leadership and boost lead generation by reaching the Australian Pharma, MedTech and Biotech industry professionals. Health Industry Hub offers unique media solutions to vendors and suppliers servicing the industry. Contact us.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Marketing & Strategy

Marketing Pharma Biotech Healthcare - PRIME Awards 2020 finalists announced

PRIME Awards 2020 finalists announced

Health Industry Hub | August 7, 2020 |

The finalists for PRIME Awards 2020 have been named, with winners to be announced via a virtual ceremony on Thursday […]

More


News & Trends - Pharmaceuticals

Pharma News - New Ventolin inhalers with dose counter reimbursed on the PBS

New Ventolin inhalers with dose counter reimbursed on the PBS

Health Industry Hub | August 7, 2020 |

Pharma News: GSK Australia is pleased to announce that a dose counter has been added to VENTOLIN (salbutamol sulfate) metered […]

More


News & Trends - Medical Technology

MedTech News - Siemens Healthineers to acquire Varian in $16.4bn deal

Siemens Healthineers to acquire Varian in $16.4bn deal

Health Industry Hub | August 5, 2020 |

MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion. Since 2012, Siemens Healthineers and Varian have […]

More


News & Trends - Pharmaceuticals

Pharma News - New anti-cancer drug for prostate cancer

New anti-cancer drug for prostate cancer

Health Industry Hub | August 5, 2020 |

Pharma News: A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis […]

More